DPP4 and latent autoimmune diabetes in adults: There is a paucity of data regarding the optimal initial treatment of LADA; however, recent studies have suggested that the use of dipeptidyl peptidase 4 inhibitors may be beneficial and can delay the destruction of beta-cells.